Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02456532 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Chronic Hypnotic Use 2
A Phase 4 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT02456532 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 41 participants.
The verdict
NCT02456532, a Phase 4 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood effects, zolpidem.
Interventions
- DRUG placebo
- DRUG Eszopiclone
- DRUG Zolpidem CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-08-05 |
| Est. Completion | 2022-02-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02456532
The ClinicalTrials.gov registry entry for NCT02456532 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT02456532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02456532 about?
NCT02456532 is a clinical study titled "Safety and Efficacy of Chronic Hypnotic Use 2". This proposal will assess risks for transition from therapeutic hypnotic use to abuse in people with insomnia. The investigators will study a hypothesized at-risk sub-population, insomniacs with hyperarousal, and compare two hypnotics, a drug with mood effects, eszopiclone, versus one without mood e...
What is the current status of trial NCT02456532?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2015-08-05. Estimated completion is 2022-02-22.
What interventions are being tested in trial NCT02456532?
The interventions under investigation include: placebo (DRUG), Eszopiclone (DRUG), Zolpidem CR (DRUG).
Who is sponsoring clinical trial NCT02456532?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.